3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Stomach Neoplasms
1
Small Cell Lung Carcinoma
1
Refractory or Relapsed Solid Tumors
1
Recurrence
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Ovarian Neoplasms
1
Neoplasm Metastasis
1
Melanoma
1
Lymphoma, Follicular
1
Leukemia, Myeloid, Acute
1
Leukemia, Biphenotypic, Acute
1
Leukemia
1
Lethal Congenital Contracture Syndrome 2
1
Hematologic Neoplasms
1
Fallopian Tube Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Breast Neoplasms
1
Barrett Esophagus
1
Advanced Breast Cancer
1
Adenocarcinoma Of Esophagus
1
Interventions
pembrolizumab
4
atezolizumab
3
Cetuximab
3
olaparib
2
Trastuzumab
2
Docetaxel
2
zimberelimab
1
tocilizumab
1
spartalizumab
1
ribociclib
1
pralsetinib
1
pertuzumab
1
pegylated granulocyte colony-stimulating factor
1
ipatasertib
1
inavolisib
1
fludarabine phosphate
1
fludarabine
1
entrectinib
1
encorafenib
1
cemiplimab
1
binimetinib
1
anlotinib
1
amivantamab
1
alectinib
1
adagrasib
1
Pemetrexed
1
Oxaliplatin
1
Nivolumab
1
Leucovorin
1
Irinotecan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Solid Tumors
×
Itraconazole
×
90 days
×
Clear all
No trials found.